Rituximab treatment for systemic sclerosis-associated interstitial lung disease: a case series of 13 patients.

Kelly Morgan, Charlotte Woollard,Dylan Beinart,Lauren V Host,Janet Roddy

Internal medicine journal（2022）

引用 1|浏览6

暂无评分

摘要

This case series suggests that rituximab might stabilise pulmonary function tests, and delay deterioration in patients with progressive SSc-ILD. These findings add to the growing body of evidence suggesting a role for rituximab in the treatment of SSc-ILD.

查看译文

关键词

interstitial lung disease,rituximab,scleroderma,systemic sclerosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要